Page last updated: 2024-09-03
plavix and papaverine
plavix has been researched along with papaverine in 1 studies
Compound Research Comparison
Studies
(plavix) | Trials
(plavix) | Recent Studies (post-2010)
(plavix) | Studies
(papaverine) | Trials
(papaverine) | Recent Studies (post-2010) (papaverine) |
|---|
| 7 | 0 | 5 | 6,027 | 305 | 355 |
Protein Interaction Comparison
| Protein | Taxonomy | plavix (IC50) | papaverine (IC50) |
|---|
| Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Rattus norvegicus (Norway rat) | | 0.076 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | | 2.3 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | | 8.8 |
| 3',5'-cyclic-AMP phosphodiesterase | Sus scrofa (pig) | | 1.7 |
| Bile salt export pump | Homo sapiens (human) | | 10 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | | 1.6 |
| Cytochrome P450 2C19 | Homo sapiens (human) | | 0.762 |
| Serine hydroxymethyltransferase, mitochondrial | Homo sapiens (human) | | 2.6915 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | Homo sapiens (human) | | 9 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Homo sapiens (human) | | 9 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | | 1.4 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | | 7.2444 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | | 1.03 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | | 9 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | | 0.697 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Rattus norvegicus (Norway rat) | | 0.036 |
| Phosphodiesterase | Sus scrofa (pig) | | 0.62 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | Homo sapiens (human) | | 0.07 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Other Studies
1 other study(ies) available for plavix and papaverine
| Article | Year |
|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |